Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intensive Insulin Therapy for Acute Ischemic Stroke
NCT02054429Phase 1Completed
- Sponsor
- University at Buffalo
- Start
- Jan 2013
- Primary completion
- Dec 2016
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of insulin aspart in ischemic stroke (2 arms), sponsored by University at Buffalo. Primary endpoint: modified Rankin Scale at 90 days. Started Jan 2013; status: completed.
02
Drugs
insulin aspart
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT02054429.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02054429.